Tonabersat, a novel gap-junction modulator for the prevention of migraine (Q37590396)

21 August 2017

1 reference

title

Tonabersat, a novel gap-junction modulator for the prevention of migraine (English)

1 reference

21 August 2017

1 reference

S D Silberstein

1

1 reference

PubMed ID

19723123

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

29 Suppl 2

1 reference

21 August 2017

28-35

1 reference

Migraine prevalence, disease burden, and the need for preventive therapy

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Indirect cost burden of migraine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Pain: Molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Calcitonin gene-related peptide (CGRP) and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Neurobiology of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Pathophysiology of headache--past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Migraine preventive medication reduces resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Topiramate for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Anticonvulsants in migraine prophylaxis: a Cochrane review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Neuromodulators for migraine prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Long-term migraine prevention with topiramate: open-label extension of pivotal trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Propranolol in the management of recurrent migraine: a meta-analytic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2009.01973.X

10.1111/J.1468-2982.2009.01973.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19723123